Gonadotropins

PreclinicalSmall molecule

UUniversity of Athens

Gonadotropins is one of 41 small molecule programs targeting Female Infertility. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Female InfertilityActive, not recruiting

Ovarian ReserveActive, not recruiting

Female InfertilityPhase 1/Phase 2

Active, not recruiting

Ovarian ReservePreclinical

Active, not recruiting

Competition

Competitive Landscape

50 competitors in Ovarian Reserve

#DrugCompanyPhaseTrials

Ulipristal Acetate

AbbVie

Approved

1 2

Folvite

Eli Lilly

Phase 3

1 3

Circadin

NNeurim Pharmaceuticals Ltd.

Phase 3

2 4

Ovitrelle

Merck & Co.

Approved

1 5

Buserelin

NNCIC Clinical Trials Group

Approved

1 6

Human Menopausal Gonadotropin

EMD Serono

Approved

1 7

Dehydroepiandrosterone

IInflabloc Pharmaceuticals

Phase 3

1 8

Trelstar

OOncoVerity, Inc.

Phase 2

1 9

Myoinositol

SSohag University

Phase 3

1 10

Dienogest

Bayer

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Ovarian Stimulation3 trials

Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response.

Unknown status·UUniversity of Athens·Phase 2/3·NCT02237755·50 enrolled

Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF

Unknown status·UUniversity of Athens·Phase 2/3·NCT02099916·50 enrolled

Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins

Unknown status·UUniversity of Athens·Phase 2/3·NCT02237781·50 enrolled

Body Weight1 trial

The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles

Unknown status·—·N/A·NCT03457233·185 enrolled

Ovarian Reserve1 trial

Comparison of 2 Ovarian Stimulation Protocols for Women With Low Ovarian Reserve

Unknown status·SSheba Medical Center·N/A·NCT02128360·200 enrolled

IVF Outcome1 trial

Effects of Intramural Fibroids on IVF Outcome

Unknown status·—·N/A·NCT03904355·200 enrolled

Phase II1 trial

Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol

Unknown status·—·N/A·NCT03484611·179 enrolled

7 more indications

Myoma1 trial

The Value of Myomectomy in Women With Intramural Myoma Before IVF.

Unknown status·—·N/A·NCT03904368·100 enrolled

Tics1 trial

Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.

Completed·IIBSA Institut Biochimique SA·Phase 1·NCT06659692·28 enrolled

Female Infertility1 trial

Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

Completed·LLebanese University·Phase 1/2·NCT04071574·200 enrolled

Ovulation Induction1 trial

Comparison of Clomiphene Citrate and Gonadotropins in Ovulation Induction Cycles

Completed·UUniversitair Ziekenhuis Brussel·Phase 4·NCT00835744·40 enrolled

Obese Women1 trial

Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment

Unknown status·—·N/A·NCT03684824·100 enrolled

Outcome1 trial

The Outcomes of ICSI Cycles With and Without Letrozole

Unknown status·MMansoura University·Phase 4·NCT04159649·224 enrolled

Infertile Patients1 trial

Poor Responders Infertile Patients -A Great Clinical Challenge

Completed·—·N/A·NCT03402620·102 enrolled

Sources

References

[1]
ClinicalTrials.gov — 14 trial records for Gonadotropins. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Gonadotropins compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Gonadotropins. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Athens company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Athens

Gonadotropins

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Ovarian Stimulation3 trials

Body Weight1 trial

Ovarian Reserve1 trial

IVF Outcome1 trial

Phase II1 trial

Myoma1 trial

Tics1 trial

Female Infertility1 trial

Ovulation Induction1 trial

Obese Women1 trial

Outcome1 trial

Infertile Patients1 trial

References

Drug Info

Quick Facts

Related News